These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 27860319)

  • 21. [The new challenge in oncology: Next-generation sequencing and its application in precision medicine].
    Calabria I; Pedrola L; Berlanga P; Aparisi MJ; Sánchez-Izquierdo D; Cañete A; Cervera J; Millán JM; Castel V
    An Pediatr (Barc); 2016 Nov; 85(5):273.e1-273.e7. PubMed ID: 27349697
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Precision cancer medicine: What has translated into clinical use in Belgium?
    Delnord M; Van Valckenborgh E; Hebrant A; Antoniou A; Van Hoof W; Waeytens A; Van den Bulcke M
    Semin Cancer Biol; 2022 Sep; 84():255-262. PubMed ID: 34129914
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Next generation sequencing and immuno-histochemistry profiling identify numerous biomarkers for personalized therapy of endometrioid endometrial carcinoma.
    El Shamieh S; Saleh F; Fawaz MA; Siest G; Farhat FS; Visvikis-Siest S
    Clin Chem Lab Med; 2017 Nov; 56(1):e19-e22. PubMed ID: 28763293
    [No Abstract]   [Full Text] [Related]  

  • 24. Practical aspects of NGS-based pathways analysis for personalized cancer science and medicine.
    Kotelnikova EA; Pyatnitskiy M; Paleeva A; Kremenetskaya O; Vinogradov D
    Oncotarget; 2016 Aug; 7(32):52493-52516. PubMed ID: 27191992
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical tumour sequencing for precision oncology: time for a universal strategy.
    Cheng ML; Berger MF; Hyman DM; Solit DB
    Nat Rev Cancer; 2018 Sep; 18(9):527-528. PubMed ID: 30030494
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Precision medicine ethics: selected issues and developments in next-generation sequencing, clinical oncology, and ethics.
    Fiore RN; Goodman KW
    Curr Opin Oncol; 2016 Jan; 28(1):83-7. PubMed ID: 26569425
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Next-generation sequencing of central nervous systems tumors: the future of personalized patient management.
    Ballester LY; Olar A; Roy-Chowdhuri S
    Neuro Oncol; 2016 Mar; 18(3):308-10. PubMed ID: 26917589
    [No Abstract]   [Full Text] [Related]  

  • 28. [PREFACE TO “NEW ERA OF PERSONALIZED MEDICINE THROUGH NEXT-GENERATION SEQUENCING”].
    Obama K
    Nihon Geka Gakkai Zasshi; 2016 Nov; 117(6):529. PubMed ID: 30173478
    [No Abstract]   [Full Text] [Related]  

  • 29. Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.
    Miles G; Rae J; Ramalingam SS; Pfeifer J
    Semin Oncol; 2015 Oct; 42(5):713-23. PubMed ID: 26433552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
    Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
    Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Personalized medical oncology. Abstracts of the Medical Oncology Group of Australia Incorporated and the Private Cancer Physicians of Australia Joint Scientific Meeting. August 11-13, 2010. Sydney, NSW, Australia.
    Asia Pac J Clin Oncol; 2010 Aug; 6 Suppl 2():37-60. PubMed ID: 20653652
    [No Abstract]   [Full Text] [Related]  

  • 33. Cancer genomics guide clinical practice in personalized medicine.
    Lehmann-Che J; Poirot B; Boyer JC; Evrard A
    Therapie; 2017 Sep; 72(4):439-451. PubMed ID: 28258721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Precision oncology in patients with nonmetastatic disease: emerging reality or illusion.
    Antoniou P; Ziogas DE; Mitsis M; Roukos DH
    Future Oncol; 2019 Jun; 15(16):1805-1810. PubMed ID: 31170806
    [No Abstract]   [Full Text] [Related]  

  • 35. Evolving landscape of tumor molecular profiling for personalized cancer therapy: a comprehensive review.
    Syn NL; Yong WP; Goh BC; Lee SC
    Expert Opin Drug Metab Toxicol; 2016 Aug; 12(8):911-22. PubMed ID: 27249175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical practice guidance for next-generation sequencing in cancer diagnosis and treatment (edition 2.1).
    Naito Y; Aburatani H; Amano T; Baba E; Furukawa T; Hayashida T; Hiyama E; Ikeda S; Kanai M; Kato M; Kinoshita I; Kiyota N; Kohno T; Kohsaka S; Komine K; Matsumura I; Miura Y; Nakamura Y; Natsume A; Nishio K; Oda K; Oda N; Okita N; Oseto K; Sunami K; Takahashi H; Takeda M; Tashiro S; Toyooka S; Ueno H; Yachida S; Yoshino T; Tsuchihara K; ; ;
    Int J Clin Oncol; 2021 Feb; 26(2):233-283. PubMed ID: 33249514
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardization efforts enabling next-generation sequencing and microarray based biomarkers for precision medicine.
    Zheng Y; Qing T; Song Y; Zhu J; Yu Y; Shi W; Pusztai L; Shi L
    Biomark Med; 2015; 9(11):1265-72. PubMed ID: 26502353
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Next-generation sequencing].
    Froňková E
    Cesk Patol; 2013 Jun; 49(3):129-32. PubMed ID: 23964910
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Next-Generation Sequencing and Result Interpretation in Clinical Oncology: Challenges of Personalized Cancer Therapy.
    Khotskaya YB; Mills GB; Mills Shaw KR
    Annu Rev Med; 2017 Jan; 68():113-125. PubMed ID: 27813876
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Personalised medicine in veterinary oncology: one to cure just one.
    Klopfleisch R
    Vet J; 2015 Aug; 205(2):128-35. PubMed ID: 25641551
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.